Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arginase in glomerulonephritis.

S N Waddington1, V Cattell

  • 1Department of Molecular Genetics, Sir Alexander Fleming Building, Imperial College School of Medicine, London, UK.

Experimental Nephrology
|May 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic therapies for movement disorders - current status.

Journal of neurology·2025
Same author

Health Science Students as PPE Coaches in the Emergency Department - a Pandemic Pilot Project.

Infection prevention in practice·2021
Same author

Delivering efficient liver-directed AAV-mediated gene therapy.

Gene therapy·2017
Same author

Proof-of-concept: neonatal intravenous injection of adeno-associated virus vectors results in successful transduction of myenteric and submucosal neurons in the mouse small and large intestine.

Neurogastroenterology and motility·2015
Same author

Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.

Gene therapy·2013
Same author

Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems.

Gene therapy·2012
Same journal

Mixed bone marrow or mixed stem cell transplantation for prevention or treatment of lupus-like diseases in mice.

Experimental nephrology·2002
Same journal

Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene.

Experimental nephrology·2002
Same journal

Activation of peroxisome proliferator-activated receptor-gamma inhibits apoptosis induced by serum deprivation in LLC-PK1 cells.

Experimental nephrology·2002
Same journal

Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells.

Experimental nephrology·2002
Same journal

Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-beta(2) gene.

Experimental nephrology·2002
Same journal

Induction of alpha-catenin, integrin alpha3, integrin beta6, and PDGF-B by 2,8-dihydroxyadenine crystals in cultured kidney epithelial cells.

Experimental nephrology·2002
See all related articles

Arginase enzymes, particularly isoform AI, are upregulated in glomerulonephritis, suggesting a role beyond urea production in kidney inflammation. Their presence at inflammatory sites may impact nitric oxide (NO) production and cell processes.

Area of Science:

  • Biochemistry
  • Immunology
  • Nephrology

Background:

  • Arginase catalyzes L-arginine to L-ornithine and urea, with two identified isoforms: AI (liver) and AII (ubiquitous).
  • Arginases are found at high concentrations at inflammatory sites, indicating roles beyond urea synthesis.
  • Regulation of arginase activity involves cytokines, substrate competition, and nitric oxide (NO) metabolism products.

Purpose of the Study:

  • To investigate the role and significance of arginase activity in glomerulonephritis.
  • To understand the potential functions of arginases at inflammatory sites, including apoptosis regulation and NO production.
  • To identify the predominant arginase isoform in inflamed glomeruli.

Main Methods:

  • Assessing arginase activity in nephritic glomeruli.

Related Experiment Videos

  • Observing changes in arginase levels with NO inhibition.
  • Identifying predominant arginase isoforms (AI vs. AII) in inflamed glomeruli.

    • Main Results:

    • Glomerulonephritis exhibits increased arginase activity in nephritic glomeruli, mirroring wound healing patterns.
    • Nitric oxide (NO) inhibition further elevates arginase levels, suggesting substrate competition.
    • Infiltrating leucocytes and mesangial cells are potential sources of arginase in the inflamed glomerulus.
    • Arginase isoform AI predominates in inflamed glomeruli, contrasting with AII's physiological prevalence.

    Conclusions:

    • Increased arginase activity in glomerulonephritis highlights its potential significance in kidney inflammation.
    • The identification of distinct arginase isoforms (AI and AII) is crucial for understanding their specific roles in disease.
    • Arginase may regulate apoptosis, NO production, and protein synthesis at inflammatory sites within the glomerulus.